MedTrace Logo

Comparison of Anti-Ischemic Drug Therapy and Percutaneous Transluminal Angioplasty After Myocardial Infarction

NCT00387231 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2006-10-12

No results posted yet for this study

Summary

Silent ischemia has been shown to negatively affect prognosis in patients after myocardial infarction. However, long-term outcome data in totally asymptomatic patients is missing and it is unknown whether angioplasty in addition to secondary preventive measures is superior to antiischemic drug therapy in these patients. Therefore, the SWISSI 2 study was started 15 years ago with the aim of comparing the effects of angioplasty with medical therapy on long-term outcome in patients with recent myocardial infarction and silent ischemia.

Conditions

  • Myocardial Ischemia

Interventions

PROCEDURE

Percutaneous coronary angioplasty/intervention (PCI)

DRUG

Anti-ischemic drug therapy

Sponsors & Collaborators

  • Luzerner Kantonsspital

    lead OTHER

Principal Investigators

  • Paul Erne, MD · Department of Cardiology, Hospital Lucerne

  • Paul Erne, MD · Department of Cardiology, Hospital Lucerne

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-06-30
Completion
2006-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00387231 on ClinicalTrials.gov